The landscape of dementia analysis has progressed considerably with the advent of innovative biomarkers, including amyloid PET scans, tau imaging, and blood-based mostly assessments that can detect Alzheimer's pathology a long time in advance of symptoms emerge. Even though these technological innovations signify impressive development in being fam